Use of a compound with affinity for the mitochondrial benzodiazepine receptor in cancer therapy
AssigneeCentre National de al Recherche Scientifique (CNRS)
InventorsGuido Kroemer, Tamara Hirsch, Didier Decaudin
Life of this patent
Estimating the term…
Abstract
The present invention relates in particular to a combination product comprising at least one compound with affinity for the mitochondrial benzodiazepine receptor, and to at least one apoptosis-inducing agent for simultaneous or separate use or for use spread out over time, which is intended for the treatment of cancer. Another aspect of the present invention relates to the use of the said compound and/or of the said combination product for the manufacture of a medicinal product intended to facilitate the induction of apoptosis.
Claims9
Combination product comprising at least one compound with affinity for the mitochioidrial benzodiazepine receptor, and at least one apoptosis-inducing agent for simultaneous or separate use or for use spread out over time, which is intended for the treatment of cancer.
Dependencies are inferred from the claim text.